Amarillo Biosciences, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Amarillo Biosciences, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Amarillo Biosciences, Inc.. The Company's principal activity is to develop biologics for the treatment of human and animal diseases. It has developed a dietary supplement and an interferon alpha lozenge, but has not commenced any significant product commercialization activities. The Company is currently in its research on human health indications for the use of low-dose orally administered natural human interferon alpha. This is particularly for the treatment of Sjogren's syndrome, Behcet's disease, polycythemia vera, essential thrombocythemia, idiopathic pulmonary fibrosis and oral warts in HIV+ patients. The Company operates in the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report